It has been hypothesized that polymorphisms of Tumor Necrosis Factor (TNF)-α gene affect the risk of developing Alzheimer's disease (AD). However, results of different studies are often inconsistent. Our aim was to investigate by meta-analysis the association of the common polymorphisms comprehensively defining the genetic variability of the TNF-α gene with AD risk. Hence, the results being stated are of a meta-analysis across studies, and that this meta-analysis does not invalidate the results of the individual studies previously performed. Seventeen studies that investigated the association between 5 TNF-α polymorphisms (−850, −308, −863, −238, and −1031) and AD were retrieved and analyzed. The model-free approach was applied to meta-analyze these case-control genetic association studies. Available data suggested a significant association between −850 polymorphism and AD risk (TT vs. TC+CC: pooled odds ratio [OR], 1.61; 95% confidence interval [CI], 1.08–2.29; p=0.02) with no evidence of between-study heterogeneity (χ2, p>0.1). Subgroup analysis suggested that the possession of T allele significantly increased the risk of AD associated with carriage of the apolipoprotein E ɛ4 allele in Caucasian Australians and Northern Europeans (TT+TC vs. CC: OR, 1.95; 95% CI, 1.45–2.62; p=0.00001; p>0.1; χ2 for heterogeneity, p>0.1). No significant difference in genotype distribution of −308 polymorphism in AD was found, with a high degree of between-study heterogeneity. For the −863 and −1031 polymorphisms we did not find an association with AD, but significant between-study heterogeneity discouraged genotype data pooling. Only four studies investigated the −238 variant and the results were not significant. Current findings support an association between −850 C>T polymorphism and the risk of developing AD; hence, they strengthen the suggestion of a potential role for anti-TNF therapy to maintain physiologic levels of TNF-α.

DI BONA, D., CANDORE, G., FRANCESCHI, C., LICASTRO, F., COLONNA-ROMANO, G., CAMMA', C., et al. (2009). Systematic review by meta-analyses on the possible role of TNF-alpha polymorphisms in association with Alzheimer's disease. BRAIN RESEARCH REVIEWS, 61(2), 60-68 [10.1016/j.brainresrev.2009.05001].

Systematic review by meta-analyses on the possible role of TNF-alpha polymorphisms in association with Alzheimer's disease.

CANDORE, Giuseppina;COLONNA ROMANO, Giuseppina;CAMMA', Calogero;LIO, Domenico;CARUSO, Calogero
2009-01-01

Abstract

It has been hypothesized that polymorphisms of Tumor Necrosis Factor (TNF)-α gene affect the risk of developing Alzheimer's disease (AD). However, results of different studies are often inconsistent. Our aim was to investigate by meta-analysis the association of the common polymorphisms comprehensively defining the genetic variability of the TNF-α gene with AD risk. Hence, the results being stated are of a meta-analysis across studies, and that this meta-analysis does not invalidate the results of the individual studies previously performed. Seventeen studies that investigated the association between 5 TNF-α polymorphisms (−850, −308, −863, −238, and −1031) and AD were retrieved and analyzed. The model-free approach was applied to meta-analyze these case-control genetic association studies. Available data suggested a significant association between −850 polymorphism and AD risk (TT vs. TC+CC: pooled odds ratio [OR], 1.61; 95% confidence interval [CI], 1.08–2.29; p=0.02) with no evidence of between-study heterogeneity (χ2, p>0.1). Subgroup analysis suggested that the possession of T allele significantly increased the risk of AD associated with carriage of the apolipoprotein E ɛ4 allele in Caucasian Australians and Northern Europeans (TT+TC vs. CC: OR, 1.95; 95% CI, 1.45–2.62; p=0.00001; p>0.1; χ2 for heterogeneity, p>0.1). No significant difference in genotype distribution of −308 polymorphism in AD was found, with a high degree of between-study heterogeneity. For the −863 and −1031 polymorphisms we did not find an association with AD, but significant between-study heterogeneity discouraged genotype data pooling. Only four studies investigated the −238 variant and the results were not significant. Current findings support an association between −850 C>T polymorphism and the risk of developing AD; hence, they strengthen the suggestion of a potential role for anti-TNF therapy to maintain physiologic levels of TNF-α.
2009
Settore MED/04 - Patologia Generale
Settore MED/05 - Patologia Clinica
DI BONA, D., CANDORE, G., FRANCESCHI, C., LICASTRO, F., COLONNA-ROMANO, G., CAMMA', C., et al. (2009). Systematic review by meta-analyses on the possible role of TNF-alpha polymorphisms in association with Alzheimer's disease. BRAIN RESEARCH REVIEWS, 61(2), 60-68 [10.1016/j.brainresrev.2009.05001].
File in questo prodotto:
File Dimensione Formato  
TNF.pdf

Solo gestori archvio

Descrizione: articolo principale
Dimensione 713.47 kB
Formato Adobe PDF
713.47 kB Adobe PDF   Visualizza/Apri   Richiedi una copia

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/10447/46619
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 85
  • ???jsp.display-item.citation.isi??? 73
social impact